What are they "waiting and watching" for?

Have they discussed with you the clinical data which will cause them to recommend you start treatment - at what PSA, will PSA doubling and velocity times be a factor, when and with what will they image...will they do any genomic testing...?

Having that type of clinical data combined with your personal health and preferences for quality of life, aggressive treatment or not...can inform any decision between you and your medical team.

The imaging could show recurrence in only the lymph nodes, if so, how many and where. Or, it could show bone and, or organ involvement. If so, where...depending upon the PSADT and PSAV, you and your medical team may decide to not doing anything and continue to actively monitor, if the PSADT